Tetramethylpyrazine ameliorates ulcerative colitis via B. pseudolongum-driven taurine metabolism and macrophage M2 polarization
Ulcerative colitis (UC), a chronic and relapsing inflammatory disorder of the colon, stems from dysregulated interactions between host immunity and the gut microbiota. However, the definitive molecular drivers and actionable therapeutic targets remainelusive.